Characteristics | n | Bmi-1 | P value | |
---|---|---|---|---|
Low expression | High expression | |||
Age at diagnosis, y | Â | Â | Â | 0.100 |
  < 6 | 43 | 30 (69.8%) | 13 (30.2%) |  |
  ≥ 6 | 42 | 22 (52.4%) | 20 (47.6%) |  |
Gender | Â | Â | Â | 0.161 |
 Male | 60 | 26 (43.3%) | 34 (56.7%) |  |
 Female | 25 | 15 (60%) | 10 (40%) |  |
WBC count (×109/L) |  |  |  | 0.153 |
  < 50 | 53 | 30 (56.6%) | 23 (43.4%) |  |
  ≥ 50 | 32 | 13 (40.6%) | 19 (59.4%) |  |
FAB classification | Â | Â | Â | 0.315a |
 L1 | 34 | 13 (38.2%) | 21 (61.8%) |  |
 L2 | 47 | 26 (55.3%) | 21 (44.6%) |  |
 L3 | 4 | 2 (50%) | 2 (50%) |  |
Immunophenotype | Â | Â | Â | 0.281a |
 T | 11 | 4 (36.4%) | 7 (63.6%) |  |
 B | 66 | 39 (59%) | 27 (41%) |  |
BCR/ABL | Â | Â | Â | 0.329a |
 + | 8 | 3 (37.5%) | 5 (62.5%) |  |
 - | 64 | 40 (62.5%) | 24 (37.5%) |  |
Prednisone-test | Â | Â | Â | 0.039 |
 PGR | 61 | 36 (59%) | 25 (41%) |  |
 PPR | 14 | 4 (28.6%) | 10 (71.4%) |  |
Risk group | Â | Â | Â | 0.002a |
 LR | 16 | 14 (87.5%) | 2 (12.5%) |  |
 IR | 31 | 16 (51.6%) | 15 (48.4%) |  |
 HR | 31 | 10 (32.3%) | 21 (67.7%) |  |